Clinical Infectious Diseases

Papers
(The H4-Index of Clinical Infectious Diseases is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Withdrawn as duplicate: Cover image/text996
In the Literature712
Reply to Focosi et al566
Correction to: Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial480
Acute Appendicitis of Unexpected Etiology312
Correction to: Prevalence of Ocular Complications in Candidemia: Defining the “Battlefield”238
Response to Rezahosseini and Barrella Harboe191
Association of Virus Variation and Vaccination Status With Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection180
Daily Second-generation Integrase Strand Inhibitors and Short-course Tuberculosis Preventive Therapy: What More Do We Need to Know?164
Don’t Put Off Until Tomorrow What You Can Do Today: Hospital Admissions as an Opportunity to Treat Hepatitis C162
Use of Carbon Dioxide Monitoring to Assess Ventilation at a National Infectious Diseases Conference155
Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort154
Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation141
Correction to: Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Val137
Pre-exposure Prophylaxis for Transgender People: A Systematic Review136
Considerations on the Associations Between Antiretroviral Regimen and Changes in Blood Pressure in the D2EFT Study133
Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis131
Modeling Respiratory Syncytial Virus Adult Vaccination in the United States With a Dynamic Transmission Model130
Because I Hope for Something Better126
Redefining Complicated Coagulase-Negative Staphylococcal Bacteremia125
Chronic Aichi Virus Infection As a Cause of Long-Lasting Multiorgan Involvement in Patients With Primary Immune Deficiencies124
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial122
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms119
2025 Content Collections from the IDSA Journals118
International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness117
Collateral Benefits and Methodological Limits of Respiratory Syncytial Virus Immunization for Infant Otitis Media and Antibiotic Use116
Invasive Listeriosis in Southern Switzerland: A Local Problem That Is Actually Global106
Does “Toxoplasma Abscess” Properly Describe Brain Lesions Caused by Toxoplasma gondii?103
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores101
A Point-of-Care Prediction Tool for Recurrent Tuberculosis101
Two for the Price of One: Can Maternal Influenza Immunization Protect Infants Against Influenza and RSV?99
Lessons I Learned from Our Soldier98
Personalized Antibiograms Using Multitask Machine Learning: Toward Mechanistic Understanding and Robust Calibration95
Blood Culture Time to Positivity and Risk of Infective Endocarditis91
Comparative Effectiveness of BNT162b2 and mRNA-1273 Booster Dose After BNT162b2 Primary Vaccination Against the Omicron Variants: A Retrospective Cohort Study Using Large-Scale Population-Based Regist86
A National Retrospective Cohort Study Comparing the Effects of Cefepime Versus Piperacillin-Tazobactam on the Development of Severe Acute Kidney Injury in Patients With Septic Shock85
Estimating Risk of Guillain-Barré Syndrome in US Medicare-enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-controlled Case Series Analysis83
Transmission of Mycobacterium tuberculosis to Healthcare Personnel Resulting From Contaminated Bone Graft Material, United States, June 2021–August 202281
Are Contact Precautions “Essential” for the Prevention of Healthcare-associated Methicillin-Resistant Staphylococcus aureus?79
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 20179
Diagnostic Uncertainties and Delayed Treatment Protocols Impact Efficacy of FMT for Clostridioides difficile Infection76
T-SPOT.TB Reactivity in Southern African Children With and Without in Utero Human Immunodeficiency Virus Exposure76
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19 Infections in Immunocompromised Patients75
Non- Klebsiella pneumoniae Carbapenemase Attributes of the Newer β-lactam/β-lactamase Inhibitors, Part 2: Burkholderia cepacia75
You’ve Come a Long Way Baby—but Many Miles Left to Go74
Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?71
Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006–202370
How Public Health Surveillance Systems Can Contribute to Antimicrobial Resistance Prevention: The Massachusetts Experience70
Beyond First Impressions69
Development of a Machine Learning Modeling Tool for Predicting HIV Incidence Using Public Health Data From a County in the Southern United States68
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012–2013 to 2018–2019 Seasons, Quebec, Canada68
Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study68
How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection67
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?66
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity65
Revisiting REVISIT: The Case for Ceftazidime/Avibactam Plus Aztreonam64
Point-of-care Ultrasound in Infectious Diseases: Current Insights and Future Perspectives64
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases64
The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination63
Valve Strands in Patients With Infective Endocarditis62
Eyes Wide Shut: A Cohort Study Questioning the Role of Fundoscopy in Infective Endocarditis Diagnosis62
COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients62
0.17186188697815